KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Cash & Current Investments: 2009-2024

Historic Cash & Current Investments for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $1.2 billion.

  • Bausch Health Companies' Cash & Current Investments rose 78.67% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 billion, marking a year-over-year increase of 76.08%. This contributed to the annual value of $1.2 billion for FY2024, which is 24.84% up from last year.
  • Latest data reveals that Bausch Health Companies reported Cash & Current Investments of $1.2 billion as of FY2024, which was up 24.84% from $962.0 million recorded in FY2023.
  • Bausch Health Companies' 5-year Cash & Current Investments high stood at $1.8 billion for FY2020, and its period low was $582.0 million during FY2021.
  • Its 3-year average for Cash & Current Investments is $918.0 million, with a median of $962.0 million in 2023.
  • In the last 5 years, Bausch Health Companies' Cash & Current Investments crashed by 67.95% in 2021 and then soared by 62.77% in 2023.
  • Bausch Health Companies' Cash & Current Investments (MRY) stood at $1.8 billion in 2020, then crashed by 67.95% to $582.0 million in 2021, then grew by 1.55% to $591.0 million in 2022, then soared by 62.77% to $962.0 million in 2023, then increased by 24.84% to $1.2 billion in 2024.
  • Its last three reported values are $1.2 billion in FY2024, $962.0 million for FY2023, and $591.0 million during FY2022.